Your browser is no longer supported. Please, upgrade your browser.
ISR Isoray, Inc. daily Stock Chart
Isoray, Inc.
Index- P/E- EPS (ttm)-0.05 Insider Own0.85% Shs Outstand68.07M Perf Week0.14%
Market Cap38.91M Forward P/E- EPS next Y-0.04 Insider Trans0.00% Shs Float68.01M Perf Month-10.23%
Income-3.50M PEG- EPS next Q-0.02 Inst Own10.40% Short Float1.93% Perf Quarter-13.01%
Sales9.70M P/S4.01 EPS this Y33.50% Inst Trans0.71% Short Ratio3.94 Perf Half Y-2.94%
Book/sh0.08 P/B7.10 EPS next Y40.00% ROA-37.70% Target Price- Perf Year83.19%
Cash/sh- P/C- EPS next 5Y- ROE-56.10% 52W Range0.29 - 1.06 Perf YTD-9.05%
Dividend- P/FCF- EPS past 5Y5.30% ROI-61.00% 52W High-46.42% Beta2.01
Dividend %- Quick Ratio3.10 Sales past 5Y16.00% Gross Margin52.90% 52W Low97.53% ATR0.03
Employees53 Current Ratio3.50 Sales Q/Q21.10% Oper. Margin-35.70% RSI (14)40.32 Volatility2.99% 5.03%
OptionableNo Debt/Eq0.00 EPS Q/Q-7.40% Profit Margin-35.70% Rel Volume2.27 Prev Close0.57
ShortableYes LT Debt/Eq0.00 EarningsSep 17 AMC Payout- Avg Volume333.22K Price0.57
Recom2.00 SMA20-0.21% SMA50-10.06% SMA200-16.00% Volume754,911 Change-1.22%
Nov-09-18Downgrade Maxim Group Buy → Hold
Feb-14-18Reiterated Maxim Group Buy $3 → $2
Nov-10-15Reiterated Maxim Group Buy $5 → $3
Jul-16-14Resumed Maxim Group Buy $3.50 → $5
Apr-02-14Reiterated Maxim Group Buy $1.50 → $3.50
Nov-01-13Initiated Maxim Group Buy $1.50
Mar-17-10Initiated C.K. Cooper Buy $1.70
Aug-21-08Downgrade Ladenburg Thalmann Buy → Neutral
May-14-08Reiterated Ladenburg Thalmann Buy $2 → $1.50
Feb-13-08Reiterated Punk, Ziegel & Co Buy $6.25 → $2
Sep-24-07Initiated Punk, Ziegel & Co Buy $6.25
Oct-19-20 04:56PM  
Sep-19-20 09:49AM  
Sep-17-20 05:15PM  
Sep-16-20 08:13AM  
Sep-10-20 08:13AM  
Jul-28-20 10:14AM  
Jun-19-20 07:06PM  
Jun-17-20 08:13AM  
Jun-04-20 12:00PM  
Jun-02-20 08:13AM  
May-14-20 09:50AM  
May-12-20 05:55PM  
May-05-20 12:30PM  
May-04-20 08:13AM  
Apr-27-20 09:04AM  
Apr-09-20 12:00PM  
Mar-22-20 09:01AM  
Feb-17-20 06:31PM  
Feb-14-20 12:00PM  
Feb-11-20 05:45PM  
Feb-05-20 08:13AM  
Feb-04-20 12:30PM  
Jan-31-20 08:13AM  
Jan-14-20 09:11AM  
Dec-09-19 12:06PM  
Dec-04-19 01:23PM  
Nov-13-19 09:00AM  
Nov-12-19 06:26PM  
Nov-05-19 10:32AM  
Nov-01-19 01:15PM  
Oct-31-19 08:13AM  
Oct-29-19 08:13AM  
Sep-30-19 11:06AM  
Sep-27-19 09:00AM  
Sep-26-19 12:51PM  
Sep-24-19 05:25PM  
Sep-18-19 08:13AM  
Sep-12-19 08:13AM  
Sep-10-19 08:13AM  
Aug-21-19 02:14PM  
Aug-13-19 08:05AM  
Jun-21-19 11:03AM  
Jun-12-19 08:13AM  
May-23-19 10:04AM  
May-09-19 07:45PM  
May-01-19 08:13AM  
Apr-25-19 10:34AM  
Apr-16-19 08:11AM  
Feb-12-19 06:20PM  
Feb-05-19 10:30AM  
Jan-30-19 08:13AM  
Jan-29-19 08:13AM  
Dec-17-18 08:13AM  
Dec-03-18 08:13AM  
Nov-26-18 08:40AM  
Nov-08-18 07:05PM  
Oct-24-18 08:13AM  
Sep-25-18 04:21PM  
Sep-10-18 08:15AM  
Sep-07-18 08:11AM  
Jul-23-18 07:00AM  
Jul-12-18 08:30AM  
Jul-10-18 09:21AM  
Jul-09-18 07:58PM  
Jun-19-18 08:00AM  
Jun-05-18 08:00AM  
May-31-18 08:30AM  
May-30-18 08:00AM  
May-25-18 08:17PM  
May-17-18 08:30AM  
May-16-18 07:55PM  
May-11-18 08:30AM  
May-03-18 06:33PM  
May-02-18 08:30AM  
Apr-26-18 08:00AM  
Apr-24-18 09:05AM  
Apr-19-18 09:00AM  
Apr-18-18 08:30AM  
Feb-09-18 05:01AM  
Feb-08-18 04:05PM  
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Woods Lori ACEOFeb 03Option Exercise0.49262,500129,750542,500Feb 05 04:47 PM
Krachon MichaelVP of Sales & MarketingNov 20Buy0.3950,00019,49550,000Nov 21 04:30 PM
Woods Lori ACEONov 15Buy0.3925,0009,745280,000Nov 19 05:04 PM
Cavanagh WilliamChief R&D OfficerNov 15Buy0.3910,0003,90020,000Nov 19 05:01 PM
Woods Lori ACEONov 14Buy0.40125,00049,550255,000Nov 19 05:04 PM